Xue Meng

1.4k total citations
84 papers, 930 citations indexed

About

Xue Meng is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Xue Meng has authored 84 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 39 papers in Oncology and 18 papers in Surgery. Recurrent topics in Xue Meng's work include Lung Cancer Treatments and Mutations (20 papers), Lung Cancer Diagnosis and Treatment (18 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Xue Meng is often cited by papers focused on Lung Cancer Treatments and Mutations (20 papers), Lung Cancer Diagnosis and Treatment (18 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Xue Meng collaborates with scholars based in China, United Kingdom and United States. Xue Meng's co-authors include Jinming Yu, Jinming Yu, Xindong Sun, Qian Zhao, Leilei Wu, Jinming Yu, Bingqing Lu, Hartmut Herrmann, Zhenshan Zhang and Jingze Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and ACS Nano.

In The Last Decade

Xue Meng

78 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue Meng China 18 404 389 223 171 101 84 930
Kazunori Okabe Japan 14 412 1.0× 261 0.7× 164 0.7× 96 0.6× 162 1.6× 77 992
Vincent Crenn France 14 213 0.5× 152 0.4× 219 1.0× 230 1.3× 65 0.6× 71 990
Zhongyang Zhang China 14 142 0.4× 147 0.4× 146 0.7× 161 0.9× 33 0.3× 47 755
Francesca Ferraraccio Italy 17 494 1.2× 594 1.5× 301 1.3× 314 1.8× 42 0.4× 30 1.2k
Rita A. Mukhtar United States 19 142 0.4× 487 1.3× 270 1.2× 147 0.9× 334 3.3× 108 1.4k
Sally Gray United Kingdom 10 314 0.8× 417 1.1× 217 1.0× 143 0.8× 47 0.5× 19 773
Beatrix Bálint United Kingdom 16 941 2.3× 554 1.4× 57 0.3× 320 1.9× 109 1.1× 29 1.5k
Kevin Hu United States 10 76 0.2× 177 0.5× 78 0.3× 385 2.3× 144 1.4× 22 948
Yijun Liu China 16 58 0.1× 166 0.4× 179 0.8× 206 1.2× 98 1.0× 22 783

Countries citing papers authored by Xue Meng

Since Specialization
Citations

This map shows the geographic impact of Xue Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Meng more than expected).

Fields of papers citing papers by Xue Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Meng. The network helps show where Xue Meng may publish in the future.

Co-authorship network of co-authors of Xue Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Meng. A scholar is included among the top collaborators of Xue Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Meng. Xue Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Liangchao, Kaikai Zhao, Xiaoli Liu, & Xue Meng. (2025). Global, regional, and national burden of esophageal cancer using the 2019 global burden of disease study. Scientific Reports. 15(1). 3284–3284. 1 indexed citations
2.
Han, Yongtao, Jianzhong Cao, Jun Wang, et al.. (2025). Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers. Cancer Biology and Medicine. 21(12). 1171–1184. 1 indexed citations
3.
Meng, Xue, et al.. (2024). Two-sample Mendelian randomization analysis of the relationship between periodontitis and risk of upper gastrointestinal cancers. Postgraduate Medical Journal. 100(1189). 820–826. 1 indexed citations
4.
5.
6.
Yuan, Jie, Shuai Liu, Xue Meng, et al.. (2024). Investigating causal associations among gut microbiota, metabolites and autoimmune hypothyroidism: a univariable and multivariable Mendelian randomization study. Frontiers in Immunology. 14. 1213159–1213159. 9 indexed citations
7.
Wu, Qi, et al.. (2024). Systematic review of Buzhong Yiqi method in alleviating cancer-related fatigue: a meta-analysis and exploratory network pharmacology approach. Frontiers in Pharmacology. 15. 1451773–1451773. 3 indexed citations
8.
Liu, Chao, Bingqing Lu, Qian Wang, et al.. (2024). High-level HONO exacerbates double high pollution of O3 and PM2.5 in China. The Science of The Total Environment. 945. 174066–174066. 5 indexed citations
9.
Han, Xiao, Yong Huang, Xue Meng, et al.. (2024). Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial. Signal Transduction and Targeted Therapy. 9(1). 241–241. 13 indexed citations
10.
Liu, Qing, et al.. (2024). Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer. Clinical & Translational Oncology. 26(10). 2513–2521. 1 indexed citations
11.
Lu, Bingqing, Xue Meng, Shanshan Dong, et al.. (2023). High-resolution mapping of regional VOCs using the enhanced space-time extreme gradient boosting machine (XGBoost) in Shanghai. The Science of The Total Environment. 905. 167054–167054. 15 indexed citations
12.
Wu, Leilei, Jingru Liu, Shasha Wang, et al.. (2022). Negative Correlation Between 18F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer. Frontiers in Endocrinology. 13. 913631–913631. 3 indexed citations
13.
Wang, Weiqing, Leilei Wu, Peng Jin, et al.. (2022). Efficacy of Immune Checkpoint Inhibitors in Patients With EGFR Mutated NSCLC and Potential Risk Factors Associated With Prognosis: A Single Institution Experience. Frontiers in Immunology. 13. 832419–832419. 11 indexed citations
14.
Liu, Jie, Leilei Wu, Samuel Seery, et al.. (2021). 18F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment. Frontiers in Oncology. 11. 671912–671912. 6 indexed citations
15.
Meng, Xue, et al.. (2020). The Predictive Value of Substructure and Whole Heart Dosimetric Variables for Cardiac Events and Overall Survival in Locally Advanced Esophageal Cancer receiving Chemoradiotherapy. International Journal of Radiation Oncology*Biology*Physics. 108(3). e588–e588. 1 indexed citations
16.
17.
Cutsem, Eric Van, Li Cp, Elżbieta Nowara, et al.. (2014). Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study. British Journal of Cancer. 111(11). 2067–2075. 35 indexed citations
18.
Su, Shu, Hao Zhou, Xue Meng, et al.. (2013). Anti-tumor Efficacy of a Hepatocellular Carcinoma Vaccine Based on Dendritic Cells Combined with Tumor-derived Autophagosomes in Murine Models. Asian Pacific Journal of Cancer Prevention. 14(5). 3109–3116. 26 indexed citations
19.
20.
Meng, Xue, Feng‐Ming Kong, & Jinming Yu. (2011). Implementation of hypoxia measurement into lung cancer therapy. Lung Cancer. 75(2). 146–150. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazunori Okabe Breakdown of academic impact, for papers by Vincent Crenn Breakdown of academic impact, for papers by Zhongyang Zhang Breakdown of academic impact, for papers by Francesca Ferraraccio Breakdown of academic impact, for papers by Rita A. Mukhtar Breakdown of academic impact, for papers by Sally Gray Breakdown of academic impact, for papers by Beatrix Bálint Breakdown of academic impact, for papers by Kevin Hu Breakdown of academic impact, for papers by Yijun Liu
Rankless by CCL
2026